Novel Assay Measures Interleukin-6 in Whole Blood Samples
|
By LabMedica International staff writers Posted on 05 Oct 2021 |
|
Image: The Pylon 3D Fully Automated Immunoassay System (Photo courtesy of ET Healthcare)
Interleukin 6 (IL-6) is a pleiotropic cytokine produced by various stromal cells and immune system cells, involved in inflammation and infection responses, regeneration process, metabolism regulation, bone homeostasis, and neural functions.
Interleukin 6 assays are useful in early detection of infections and risk stratification of critically ill patients, so an assay with a short turnaround-time and near-patient use is preferred. It is indicated in many diseases such as infection, injury, trauma, stress, neoplasia, post-surgery complications, and chronic inflammatory diseases.
Clinical Laboratorians at the Children’s Hospital of Fudan University (Shanghai, China) included in a study pediatric patients, admitted to the Emergency Department (ED) between April and September 2020 with suspected infection. Blood samples and respiratory tract samples were collected for routine clinical laboratory tests, that is, hematology tests, CRP, PCT, viral antigen, or antibody tests and microbiology culture tests.
The study evaluated the performance of the Pylon IL-6 assay (ET Healthcare, Shanghai, China) based on a cyclic enhanced fluorescent immunoassay performed on a fully automated, benchtop Pylon 3D immuno-analyzer. A total of 100 remnant serum samples from outpatients and ED patients were measured by the Pylon assay and the Elecsys IL-6 assay on a Cobas e 602 (Roche Diagnostics, Rotkreuz, Switzerland). The team carried out imprecision, linearity and comparison studies using serum and plasma samples according to CLSI EP guidelines. The stability of whole blood (WB) samples during storage was assessed.
The investigators reported that the results of serum samples measured by Pylon assays correlated to those measured by Roche assays, as well as to those of matched whole blood samples measured by Pylon assays. IL-6 in whole blood was found stable for ~8 hours at room temperature. Pylon IL-6 results of whole blood samples from 179 pediatric patients with suspected infection showed an AUC of 0.842 in diagnosis of bacterial infection. The within-run CVs and total CVs of Pylon IL-6 assay were determined as 1.8% and 3.0% at 159.3 pg/mL and 3.5% and 4.7% at 8009.9 pg/mL, respectively. The method showed linearity between 1.5 and 42,854 pg/mL. The turnaround time of Pylon IL-6 assay was only an hour when using whole blood samples.
The authors concluded that the new Pylon IL-6 assay demonstrated comparable performance to those assays performed on clinical laboratory instruments. Further, the feature of WB sampling offers advantages in ED or other near-patient settings where turnaround time (TAT) is critical. The study was published on September 20, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
Children’s Hospital of Fudan University
ET Healthcare
Roche Diagnostics
Interleukin 6 assays are useful in early detection of infections and risk stratification of critically ill patients, so an assay with a short turnaround-time and near-patient use is preferred. It is indicated in many diseases such as infection, injury, trauma, stress, neoplasia, post-surgery complications, and chronic inflammatory diseases.
Clinical Laboratorians at the Children’s Hospital of Fudan University (Shanghai, China) included in a study pediatric patients, admitted to the Emergency Department (ED) between April and September 2020 with suspected infection. Blood samples and respiratory tract samples were collected for routine clinical laboratory tests, that is, hematology tests, CRP, PCT, viral antigen, or antibody tests and microbiology culture tests.
The study evaluated the performance of the Pylon IL-6 assay (ET Healthcare, Shanghai, China) based on a cyclic enhanced fluorescent immunoassay performed on a fully automated, benchtop Pylon 3D immuno-analyzer. A total of 100 remnant serum samples from outpatients and ED patients were measured by the Pylon assay and the Elecsys IL-6 assay on a Cobas e 602 (Roche Diagnostics, Rotkreuz, Switzerland). The team carried out imprecision, linearity and comparison studies using serum and plasma samples according to CLSI EP guidelines. The stability of whole blood (WB) samples during storage was assessed.
The investigators reported that the results of serum samples measured by Pylon assays correlated to those measured by Roche assays, as well as to those of matched whole blood samples measured by Pylon assays. IL-6 in whole blood was found stable for ~8 hours at room temperature. Pylon IL-6 results of whole blood samples from 179 pediatric patients with suspected infection showed an AUC of 0.842 in diagnosis of bacterial infection. The within-run CVs and total CVs of Pylon IL-6 assay were determined as 1.8% and 3.0% at 159.3 pg/mL and 3.5% and 4.7% at 8009.9 pg/mL, respectively. The method showed linearity between 1.5 and 42,854 pg/mL. The turnaround time of Pylon IL-6 assay was only an hour when using whole blood samples.
The authors concluded that the new Pylon IL-6 assay demonstrated comparable performance to those assays performed on clinical laboratory instruments. Further, the feature of WB sampling offers advantages in ED or other near-patient settings where turnaround time (TAT) is critical. The study was published on September 20, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
Children’s Hospital of Fudan University
ET Healthcare
Roche Diagnostics
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read more
.jpg "Image: The new urine-based test detects high-grade prostate cancer (Photo courtesy of U-M Rogel Cancer Center)"){kind=small}
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg "Image: Dr. Sam Lodge found that metabolic signatures can shift the speed of sepsis diagnosis (Photo courtesy of Murdoch University)")
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read more
Pathology
view channel
Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more.jpg "Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)")
Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more
Siemens to Close Fast Track Diagnostics Business
Siemens Healthineers (Erlangen, Germany) has announced its intention to close its Fast Track Diagnostics unit, a small collection of polymerase chain reaction (PCR) testing products that is part of the... Read more